Iowa Dems Get Ad Support For Vote To Lower Prescription Drug Costs

After the U.S. House passed The Elijah E. Cummings Lower Drug Costs Now Act of 2019 yesterday, the Democratic Congressional Campaign Committee is running targeted ads to highlight Representative Cindy Axne and Abby Finkenauer’s votes to lower prescription drug prices.

The bill has been in the works for months, and yesterday there was discussion on the floor that included Axne and Finkenauer speaking about Iowa families, and adding their own amendments to the bill.

“Seniors and working families are demanding action to lower out of control prescription drug costs and Representative Abby Finkenauer is fighting for their priorities,” said DCCC spokesperson Brooke Goren, in a statement. “This targeted ad buy is a reminder that while Representative Finkenauer continues to put the priorities of Iowans first, Washington Republicans once again showed they will always prioritize padding the pockets of their special interest backers over the people they were elected to represent.”

The ads in Iowa will highlight the votes of Finkenauer and Axne to pass the bill, as well as Steve King’s vote against the bill.

“This targeted ad buy is a reminder that King and Washington Republicans once again showed they will always prioritize padding the pockets of their special interest backers over the people they were elected to represent,” Goren said, in a statement.

“The nonpartisan Congressional Budget Office stated in October that H.R. 3 would lower domestic drug prices and save at least $345 billion for the American people,” the DCCC said in a statement. “This legislation will save a family of four approximately $1,920 per year. In IA-01 specifically, there are 126,875 people enrolled in a Medicare Part D plan and 574,173 people enrolled in private health insurance – all of whom would benefit from the passage of this legislation.”

[inline-ad id=”0″]

“Instead of supporting this commonsense bill to lower drug prices, Republicans in Washington once again stood with big drug manufacturers and voted ‘no.’ This comes after Republicans handed out billions to those same wealthy drug makers just last year,” the organization added.

The ads will be featured in sponsored posts on social media, targeting voters in the districts of House members in battleground states.

H.R. 3 will move on to the Senate, where Republicans controlling the majority will likely not take it up at all. Because of that, Li Zhou from Vox writes that the passing of the bill is, “widely seen as a values statement for Democrats seeking to put a stake in the ground. It’s also an achievement lawmakers can point to in the 2020 elections to show that they kept a midterms campaign promise — and advanced important legislation — even as the party continues to work on the impeachment inquiry.”

[inline-ad id=”2″]

By Josh Cook
Posted 12/13/19